Log in

OTCMKTS:PBIOPressure Biosciences Stock Price, Forecast & News

$2.13
-0.02 (-0.93 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.99
Now: $2.13
$2.20
50-Day Range
$2.15
MA: $2.58
$3.88
52-Week Range
$0.60
Now: $2.13
$4.49
Volume10,596 shs
Average Volume15,772 shs
Market Capitalization$6.73 million
P/E RatioN/A
Dividend YieldN/A
Beta1.08
Pressure BioSciences, Inc. develops pressure cycling technology (PCT) solutions. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations, including Barocycler 2320EXT, Barozyme-HT48, Barocycler NEP3229, HUB440, HUB880, and The Shredder SG3. It also distributes cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as PCT MicroTubes, PCT-MicroCaps, PCT-Micro-Pestle, PULSE Tubes, and BaroFlex 8-well Processing Strips, as well as application specific kits. Pressure BioSciences, Inc. serves researchers at academic laboratories; government agencies; and biotechnology, pharmaceutical, and other life sciences institutions in the United States, Europe, and Asia. Pressure BioSciences, Inc. has a collaboration with NutraFuels, Inc. for the development of water-soluble Nanoemulsion-based nutraceuticals. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was founded in 1978 and is based in South Easton, Massachusetts.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.57 out of 5 stars


Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PBIO
CUSIPN/A
Phone508-230-1828

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.81 million
Book Value($13.00) per share

Profitability

Net Income$-11,660,000.00
Net Margins-644.25%

Miscellaneous

Employees17
Market Cap$6.73 million
Next Earnings Date8/20/2020 (Estimated)
OptionableNot Optionable

Receive PBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for PBIO and its competitors with MarketBeat's FREE daily newsletter.

Pressure Biosciences (OTCMKTS:PBIO) Frequently Asked Questions

How has Pressure Biosciences' stock been impacted by COVID-19 (Coronavirus)?

Pressure Biosciences' stock was trading at $2.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PBIO shares have increased by 6.5% and is now trading at $2.13. View which stocks have been most impacted by Coronavirus.

When is Pressure Biosciences' next earnings date?

Pressure Biosciences is scheduled to release its next quarterly earnings announcement on Thursday, August 20th 2020. View our earnings forecast for Pressure Biosciences.

How were Pressure Biosciences' earnings last quarter?

Pressure Biosciences Inc (OTCMKTS:PBIO) announced its earnings results on Tuesday, May, 15th. The company reported ($1.64) EPS for the quarter. The company had revenue of $0.61 million for the quarter. View Pressure Biosciences' earnings history.

Has Pressure Biosciences been receiving favorable news coverage?

Media headlines about PBIO stock have trended somewhat negative this week, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Pressure Biosciences earned a news sentiment score of -1.3 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news about Pressure Biosciences.

Who are some of Pressure Biosciences' key competitors?

Some companies that are related to Pressure Biosciences include Aethlon Medical (AEMD), Precipio (PRPO), Scientific Industries (SCND), Arrayit (ARYC) and PositiveID (PSID). View all competitors.

What other stocks do shareholders of Pressure Biosciences own?

Who are Pressure Biosciences' key executives?

Pressure Biosciences' management team includes the following people:
  • Mr. Richard T. Schumacher, Founder, Pres, CEO, Treasurer, Clerk, Sec. & Director (Age 69)
  • Dr. Alexander V. Lazarev, Chief Science Officer (Age 54)
  • Dr. Edmund Y. Ting Ph.D., Sc.D. Ph.D., Sr. VP of Engineering (Age 64)
  • Mr. Richard P. Thomley, Acting Chief Financial Officer (Age 67)
  • Dr. Bradford Addison Young, Sr. VP & Chief Commercial Officer (Age 50)

What is Pressure Biosciences' stock symbol?

Pressure Biosciences trades on the OTCMKTS under the ticker symbol "PBIO."

How do I buy shares of Pressure Biosciences?

Shares of PBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Pressure Biosciences' stock price today?

One share of PBIO stock can currently be purchased for approximately $2.13.

How big of a company is Pressure Biosciences?

Pressure Biosciences has a market capitalization of $6.73 million and generates $1.81 million in revenue each year. Pressure Biosciences employs 17 workers across the globe.

What is Pressure Biosciences' official website?

The official website for Pressure Biosciences is www.pressurebiosciences.com.

How can I contact Pressure Biosciences?

Pressure Biosciences' mailing address is 14 NORFOLK AVENUE, SOUTH EASTON MA, 02375. The company can be reached via phone at 508-230-1828 or via email at [email protected]

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.